Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,900 | -392,100 | -61,800 | 50,500 | 6,300 |
| Depreciation Amortization | 115,900 | 482,200 | 46,100 | 47,700 | 38,300 |
| Income taxes - deferred | -10,400 | -39,400 | -22,400 | N/A | -3,000 |
| Accounts receivable | 30,900 | -6,600 | 39,000 | -24,700 | -10,800 |
| Accounts payable and accrued liabilities | 600 | -900 | -14,400 | 35,400 | -11,900 |
| Other Working Capital | 20,200 | 35,000 | -18,000 | -24,300 | 24,500 |
| Other Operating Activity | -9,600 | 22,500 | 63,900 | 6,300 | 43,900 |
| Operating Cash Flow | $74,700 | $100,700 | $32,400 | $90,900 | $87,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27,600 | -17,800 | -17,800 | -19,300 | -21,000 |
| Net Acquisitions | -28,000 | 2,100 | 39,400 | -116,100 | N/A |
| Other Investing Activity | -5,000 | -11,800 | 0 | 0 | 0 |
| Investing Cash Flow | $-60,600 | $-27,500 | $21,600 | $-135,400 | $-21,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 20,000 | 55,000 | 400,000 | 20,000 |
| Debt Repayment | -34,400 | -53,600 | -119,700 | -296,600 | -70,000 |
| Common Stock Issued | 700 | 1,100 | 1,300 | 1,700 | 6,200 |
| Common Stock Repurchased | -3,300 | -12,800 | -19,100 | -45,500 | -11,500 |
| Other Financing Activity | 0 | -3,800 | -11,700 | -2,900 | 0 |
| Financing Cash Flow | $-37,000 | $-49,100 | $-94,200 | $56,700 | $-55,300 |
| Exchange Rate Effect | 5,000 | -4,100 | 200 | -3,000 | -4,000 |
| Beginning Cash Position | 107,700 | 87,700 | 127,700 | 118,500 | 111,500 |
| End Cash Position | 89,800 | 107,700 | 87,700 | 127,700 | 118,500 |
| Net Cash Flow | $-17,900 | $20,000 | $-40,000 | $9,200 | $7,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 74,700 | 100,700 | 32,400 | 90,900 | 87,300 |
| Capital Expenditure | -31,600 | -17,800 | -17,800 | -19,300 | -21,000 |
| Free Cash Flow | 43,100 | 82,900 | 14,600 | 71,600 | 66,300 |